Clinical trials sponsored by Ottawa Heart Institute Research Corporation
9
Recruiting trials
14
Conditions studied
Phase breakdown
Phase 2 1Phase 3 2Not applicable 7
Conditions studied
Recruiting trials led by Ottawa Heart Institute Research Corporation
- Biomarker Guided Discharge of Heart Failure Patients
- Canagliflozin Targeting Vascular Inflammation
- Exercise Training in Patients With Persistent or Permanent Atrial Fibrillation
- Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus in The Emergency Department (LA CLOTTED)
- MAX - SHOCK Clinical Trial
- Predicting Development of SCAF in Device Patients
- QOL Improvement After Cardioversion of Persistent AF (QOL-CAFRCT)
- Randomized Controlled Trial- Ablation Strategy for Paroxysmal Atrial Fibrillation - Trigger and Substrate Guided Wide Area Radiofrequency Ablation Compared to Pulsed Field Ablation Pulmonary Vein Isolation
- Semaglutide for Smoking Cessation in Patients With Diabetes
Common questions
How many trials is Ottawa Heart Institute Research Corporation recruiting for?
Ottawa Heart Institute Research Corporation is the lead sponsor of 9 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.